Showing 221-240 of 511 for: Cochrane Systematic Reviews > Infectious disease 
- Herbal medicines for treating HIV infection and AIDS
Cochrane Systematic Reviews, 20-Jul-2005
HIV-infected people and AIDS patients often seek complementary therapies including herbal medicines due to reasons such as unsatisfactory effects, high cost, non-availability, or adverse effects of conventional medicines.
- High first dose quinine regimen for treating severe malaria
Cochrane Systematic Reviews, 19-Jul-2004
Quinine is used for treating severe malaria. There are arguments for giving an initial high dose. We examined the evidence for and against this policy.
- Home versus hospital intravenous antibiotic therapy for cystic fibrosis
Cochrane Systematic Reviews, 15-Dec-2015
Recurrent endobronchial infection in cystic fibrosis requires treatment with intravenous antibiotics for several weeks usually in hospital, affecting health costs and quality of life for patients and their families. This is an update of a previously publi
- Home‐based care for reducing morbidity and mortality in people infected with HIV/AIDS
Cochrane Systematic Reviews, 20-Jan-2010
Home-based care (HBC), to promote quality-of-life and limit hospital care, is used in many countries, especially where public health services are overburdened.
- Home‐based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing
Cochrane Systematic Reviews, 7-Jul-2010
The low uptake of HIV voluntary counselling and testing (VCT) has hindered global attempts to prevent new HIV infections and has limited scale-up of HIV care and treatment. Globally, only 10% of HIV-infected individuals are aware of their HIV status. One
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
Cochrane Systematic Reviews, 12-Dec-2012
Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review ori
- Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
Cochrane Systematic Reviews, 26-Jul-2014
PRO 140 (a humanized form of the PA14 antibody, a monoclonal CCR5 antibody) inhibits CCR5-tropic (R5) type 1 human immunodeficiency virus (HIV). This may be an effective new treatment with the potential to address the limitations of currently available th
- Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients
Cochrane Systematic Reviews, 19-Jul-2004
Hypertonic solutions are considered to have a greater ability to expand blood volume and thus elevate blood pressure and can be administered as a small volume infusion over a short time period. On the other hand, the use of hypertonic solutions for volume
- Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
Cochrane Systematic Reviews, 7-Feb-2010
Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival.
- Immunoglobulin for preventing respiratory syncytial virus infection
Cochrane Systematic Reviews, 16-Jun-2008
Respiratory Syncytial virus, the most important cause of lower respiratory tract infections in infants and young children in industrialized countries, is associated with increased morbidity in premature infants with or without bronchopulmonary dysplasia a
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 17-Mar-2010
Cytomegalovirus (CMV) is the most common virus causing disease and death in solid organ transplant recipients during the first six months post-transplant. Previous systematic reviews have demonstrated the efficacy of antiviral medications used prophylacti
- Immunostimulants for preventing respiratory tract infection in children
Cochrane Systematic Reviews, 18-Oct-2006
Acute respiratory tract infections (ARTIs) are a major cause of childhood morbidity and mortality. Immunostimulants (IS) may reduce the incidence of ARTIs.
- Immunosuppressive agents for myasthenia gravis
Cochrane Systematic Reviews, 2-Nov-2008
The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear.
- Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Cochrane Systematic Reviews, 19-Jul-2006
Immunosuppressive and cytotoxic agents have been used as both an alternative to oral corticosteroids, and as a means of maintaining a low dose of steroids in the treatment of pulmonary sarcoidosis.
- Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
Cochrane Systematic Reviews, 15-Nov-2021
Primary membranous nephropathy (PMN) is a common cause of nephrotic syndrome in adults. Without treatment, approximately 30% of patients will experience spontaneous remission and one third will have persistent proteinuria. Approximately one-third of patie
- Incentives and enablers to improve adherence in tuberculosis
Cochrane Systematic Reviews, 4-Sep-2015
Patient adherence to medications, particularly for conditions requiring prolonged treatment such as tuberculosis (TB), is frequently less than ideal and can result in poor treatment outcomes. Material incentives to reward good behaviour and enablers to re
- Indoor residual spraying for preventing malaria
Cochrane Systematic Reviews, 14-Apr-2010
Primary malaria prevention on a large scale depends on two vector control interventions: indoor residual spraying (IRS) and insecticide-treated mosquito nets (ITNs). Historically, IRS has reduced malaria transmission in many settings in the world, but the
- Infection control strategies for preventing the transmission of meticillin‐resistant Staphylococcus aureus (MRSA) in nursing homes for older people
Cochrane Systematic Reviews, 19-Nov-2013
Nursing homes for older people provide an environment likely to promote the acquisition and spread of meticillin-resistant Staphylococcus aureus (MRSA), putting residents at increased risk of colonisation and infection. It is recognised that infection pre
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions
Cochrane Systematic Reviews, 2-Jun-2016
A systematic review found that 3% of working adults who had received influenza vaccine and 5% of those who were unvaccinated had laboratory-proven influenza per season; in healthcare workers (HCWs) these percentages were 5% and 8% respectively. Healthcare
- Influenza vaccination in children being treated with chemotherapy for cancer
Cochrane Systematic Reviews, 1-Aug-2013
Influenza infection is a potential cause of severe morbidity in children with cancer; therefore vaccination against influenza is recommended. However, data are conflicting regarding the immune response to influenza vaccination in children with cancer, and
